Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JBM-TC4 for Prevention of Acute Radiation-induced Dermatitis in Breast Cancer
NCT02289365Phase 2Unknown
- Sponsor
- Joben Bio-Medical Co., Ltd.
- Start
- Nov 2014
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JBM TC4 in radiation dermatitis (3 arms), sponsored by Joben Bio-Medical Co., Ltd. Primary endpoint: Radiation Dermatitis Severity Scale. Status: unknown.
02
Drugs
JBM TC4
03
Conditions
radiation dermatitis
Beyond the preview
Go deeper on NCT02289365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02289365.